Summary & Overview
CPT 85520: Heparin Concentration Measurement in Plasma
CPT code 85520 represents a laboratory assay to measure heparin concentration in a plasma specimen. This diagnostic test informs anticoagulation management, monitoring of therapeutic heparin levels, and assessment of bleeding or thrombotic risk, making it a clinically relevant code across inpatient and outpatient laboratory settings nationwide. The code matters for hospital and clinical laboratory billing, laboratory utilization tracking, and payer coverage policy discussions because heparin monitoring impacts patient safety and resource use.
Key payers considered in this analysis include Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for the test, typical sites of service, and how the code is used in practice. The publication also outlines benchmarking elements, common billing modifiers provided in the input, and areas where policy updates or payer-specific coverage rules commonly arise. Where specific payer policy detail is not provided, the report notes that data is not available in the input.
This national-level summary is intended to orient laboratory, billing, and policy stakeholders to the clinical purpose of CPT code 85520, common operational settings for the service, and the scope of payer coverage included in the accompanying analysis.
Billing Code Overview
CPT code 85520 describes a laboratory assay in which a medical laboratory analyst measures heparin concentration in a plasma specimen. The service is a laboratory diagnostic test used to assess anticoagulant levels, monitor anticoagulation therapy, or evaluate bleeding/thrombotic risk related to heparin administration.
-
Service type: Laboratory diagnostic assay
-
Typical site of service: Clinical laboratory or hospital laboratory performing plasma-based coagulation testing
Data not available in the input for payers, associated taxonomies, ICD-10 diagnoses, related codes, and service line.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult hospitalized receiving intravenous unfractionated heparin for treatment of acute venous thromboembolism or as anticoagulation during extracorporeal membrane oxygenation (ECMO) or cardiopulmonary bypass. The physician orders quantitative heparin concentration measurement when activated partial thromboplastin time (aPTT) or anti‑Xa levels are discordant with clinical expectations, when there is concern for heparin overdose, heparin resistance, or suspected heparin contamination, or prior to urgent invasive procedures where precise heparin level is required.
Workflow: A clinician places an order for heparin concentration testing. A phlebotomist draws a plasma specimen into an appropriate anticoagulated tube. The specimen is transported to the clinical laboratory. A laboratory technologist or clinical chemist performs the assay to determine plasma heparin concentration and documents the result in the laboratory information system. The result is reviewed by the ordering clinician to guide adjustment of heparin dosing or to inform procedural timing.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the professional interpretation component of a lab test (if applicable in split billing environments). |